216 related articles for article (PubMed ID: 24949465)
1. Neuropathologic implication of peripheral neuregulin-1 and EGF signals in dopaminergic dysfunction and behavioral deficits relevant to schizophrenia: their target cells and time window.
Nawa H; Sotoyama H; Iwakura Y; Takei N; Namba H
Biomed Res Int; 2014; 2014():697935. PubMed ID: 24949465
[TBL] [Abstract][Full Text] [Related]
2. Pallidal hyperdopaminergic innervation underlying D2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF.
Sotoyama H; Zheng Y; Iwakura Y; Mizuno M; Aizawa M; Shcherbakova K; Wang R; Namba H; Nawa H
PLoS One; 2011; 6(10):e25831. PubMed ID: 22022452
[TBL] [Abstract][Full Text] [Related]
3. Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia.
Kato T; Abe Y; Sotoyama H; Kakita A; Kominami R; Hirokawa S; Ozaki M; Takahashi H; Nawa H
Mol Psychiatry; 2011 Mar; 16(3):307-20. PubMed ID: 20142818
[TBL] [Abstract][Full Text] [Related]
4. Perinatal Exposure to Neuregulin-1 Results in Disinhibition of Adult Midbrain Dopaminergic Neurons: Implication in Schizophrenia Modeling.
Namba H; Okubo T; Nawa H
Sci Rep; 2016 Mar; 6():22606. PubMed ID: 26935991
[TBL] [Abstract][Full Text] [Related]
5. [Vulnerability of dopamine circuit development to cytokines from the periphery: implication in schizophrenia].
Sotoyama H; Nawa H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):209-15. PubMed ID: 22256609
[TBL] [Abstract][Full Text] [Related]
6. Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development.
Futamura T; Kakita A; Tohmi M; Sotoyama H; Takahashi H; Nawa H
Mol Psychiatry; 2003 Jan; 8(1):19-29. PubMed ID: 12556905
[TBL] [Abstract][Full Text] [Related]
7. ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions.
Mizuno M; Sotoyama H; Namba H; Shibuya M; Eda T; Wang R; Okubo T; Nagata K; Iwakura Y; Nawa H
Transl Psychiatry; 2013 Apr; 3(4):e252. PubMed ID: 23632456
[TBL] [Abstract][Full Text] [Related]
8. Schizophrenia Animal Modeling with Epidermal Growth Factor and Its Homologs: Their Connections to the Inflammatory Pathway and the Dopamine System.
Sotoyama H; Namba H; Tohmi M; Nawa H
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830741
[TBL] [Abstract][Full Text] [Related]
9. Neurobehavioral deficits of epidermal growth factor-overexpressing transgenic mice: impact on dopamine metabolism.
Eda T; Mizuno M; Araki K; Iwakura Y; Namba H; Sotoyama H; Kakita A; Takahashi H; Satoh H; Chan SY; Nawa H
Neurosci Lett; 2013 Jun; 547():21-5. PubMed ID: 23669645
[TBL] [Abstract][Full Text] [Related]
10. Neonatal exposure to epidermal growth factor induces dopamine D2-like receptor supersensitivity in adult sensorimotor gating.
Sotoyama H; Namba H; Takei N; Nawa H
Psychopharmacology (Berl); 2007 Apr; 191(3):783-92. PubMed ID: 17096084
[TBL] [Abstract][Full Text] [Related]
11. Cytokine hypothesis of schizophrenia pathogenesis: evidence from human studies and animal models.
Watanabe Y; Someya T; Nawa H
Psychiatry Clin Neurosci; 2010 Jun; 64(3):217-30. PubMed ID: 20602722
[TBL] [Abstract][Full Text] [Related]
12. Transient overexposure of neuregulin 3 during early postnatal development impacts selective behaviors in adulthood.
Paterson C; Law AJ
PLoS One; 2014; 9(8):e104172. PubMed ID: 25093331
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor administered in the periphery influences excitatory synaptic inputs onto midbrain dopaminergic neurons in postnatal mice.
Namba H; Zheng Y; Abe Y; Nawa H
Neuroscience; 2009 Feb; 158(4):1731-41. PubMed ID: 19041374
[TBL] [Abstract][Full Text] [Related]
14. Experimental schizophrenia models in rodents established with inflammatory agents and cytokines.
Nawa H; Yamada K
Methods Mol Biol; 2012; 829():445-51. PubMed ID: 22231831
[TBL] [Abstract][Full Text] [Related]
15. Neuregulin-1 mutant mice indicate motor and sensory deficits, indeed few references for schizophrenia endophenotype model.
Schneider S; Götz K; Birchmeier C; Schwegler H; Roskoden T
Behav Brain Res; 2017 Mar; 322(Pt A):177-185. PubMed ID: 28089851
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease.
Carlsson T; Schindler FR; Höllerhage M; Depboylu C; Arias-Carrión O; Schnurrbusch S; Rösler TW; Wozny W; Schwall GP; Groebe K; Oertel WH; Brundin P; Schrattenholz A; Höglinger GU
J Neurochem; 2011 Jun; 117(6):1066-74. PubMed ID: 21517849
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the ErbB signaling in adolescence increases striatal dopamine levels and affects learning and hedonic-like behavior in the adult mouse.
Golani I; Tadmor H; Buonanno A; Kremer I; Shamir A
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1808-18. PubMed ID: 25451700
[TBL] [Abstract][Full Text] [Related]
18. Transient activation of dopaminergic neurons during development modulates visual responsiveness, locomotion and brain activity in a dopamine ontogeny model of schizophrenia.
Calcagno B; Eyles D; van Alphen B; van Swinderen B
Transl Psychiatry; 2013 Jan; 3(1):e206. PubMed ID: 23299394
[TBL] [Abstract][Full Text] [Related]
19. Post-pubertal Difference in Nigral Dopaminergic Cells Firing in the Schizophrenia Model Prepared by Perinatal Challenges of a Cytokine, EGF.
Namba H; Nawa H
Neuroscience; 2020 Aug; 441():22-32. PubMed ID: 32531471
[TBL] [Abstract][Full Text] [Related]
20. ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors.
Skirzewski M; Karavanova I; Shamir A; Erben L; Garcia-Olivares J; Shin JH; Vullhorst D; Alvarez VA; Amara SG; Buonanno A
Mol Psychiatry; 2018 Nov; 23(11):2227-2237. PubMed ID: 28727685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
